Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q1 FY23 results · Apr–Jun 2022
Amrutanjan Health Care reported revenue from operations of ₹70.95 crore (down 9.3% from Q1 FY22) and net profit of ₹3.66 crore (down 69.6% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a standalone basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 70.95 | 78.21 | −9.3% | 106.55 | −33.4% |
| Other income | 3.01 | 2.74 | +10.0% | 5.16 | −41.6% |
| Total income | 73.97 | 80.95 | −8.6% | 111.71 | −33.8% |
| Profit before tax | 5.25 | 16.29 | −67.8% | 20.02 | −73.8% |
| Net profit for the period | 3.66 | 12.06 | −69.6% | 14.71 | −75.1% |
| EPS, basic (₹) | 1.25 | 4.12 | −69.7% | 5.09 | −75.4% |
| Net margin (%) | 5.2 | 15.4 | 13.8 |
Standalone
- Filed with BSE
- 06 Sep 2022, 14:45 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE